- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02949544
Water Immersion in Chronic Stable Heart Failure (IMMERSE-HF)
June 17, 2019 updated by: Hull University Teaching Hospitals NHS Trust
Water Immersion and Water-based Exercise in Patients With Chronic Stable Heart Failure: A Pilot Study
This study aims to investigate the effects of water immersion and exercise on heart function and blood flow in patients with chronic stable heart failure.
Study Overview
Study Type
Interventional
Enrollment (Actual)
27
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cottingham, United Kingdom, HU165JQ
- Castle Hill Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age >18
- Established diagnosis of heart failure with NTpro BNP >100
Exclusion Criteria:
- Uncontrolled or severe heart failure, defined by NYHA class IV symptoms (breathlessness at rest)
- Severe fluid overload characterised as more than minimal pitting oedema of the ankles only
- Presence of haemodynamically significant valvular heart disease in the opinion of the investigator
- Haemoglobin <125 g/L
- Weight >120 kilograms
- Requiring long term oxygen supplementation in the community
- Hospitalisation for any cause within the last 6 weeks, that in the opinion of the investigator would affect the patients wellbeing in this study
- Unstable or severe stable angina that requires three or more antianginals
- Patients known to have disease causing immunocompromise such as HIV infection or undergoing chemotherapy
- Patients with active infection
- Dialysis patients
- Uncontrolled seizures; patients in whom the pool environment may trigger seizures, new diagnosis of epilepsy
- Insulin treated diabetic patients with hypoglycaemic episodes in the last 3 months.
- Pregnant women
- Central venous lines which are not tunnelled and are exposed superficially.
- Open access ports to lungs including tracheotomy sites
- Ventilation tubes for ears
- Nasogastric or gastrostomy tube in situ
- Presence of colostomy, ileostomy or urostomy.
- Presence of open, macerated, infected or non-intact skin or oedema with leakage of serous fluid.
- Skin condition such as severe eczema or psoriasis
- Any surgery or invasive devices fitted within the last 4 weeks
- Any form of mobility impairment requiring mobility aids (e.g. stick or wheelchair) or rendering patient unable to perform gentle exercises, including recent injury or trauma
- History of chlorine sensitivity
- Urinary or faecal incontinence
- Hydrophobia
- Unable to give consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
OTHER: water immersion
patients with heart failure will be immersed to the neck for 15 minutes
|
warm water immersion
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cardiac output
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Heart rate (beats/minute)
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
|
Blood pressure (mmHg)
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
|
systemic vascular resistance (dyn·s/cm5)
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
|
Stroke volume (millilitres)
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
|
Jugular venous pressure (not raised, raised 1-4cm, raised to earlobes, undetectable)
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
|
BORG dyspnoea score (score between 1-10)
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
|
cardiac output (milliliters/minute)
Time Frame: 3 minutes of exercise in water
|
3 minutes of exercise in water
|
|
N-terminal pro b-type natriuretic peptide (ng/L)
Time Frame: 10 mins after water immersion
|
10 mins after water immersion
|
|
Left ventricular end systolic diameter (mm)
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
|
Left ventricular end diastolic diameters (mm)
Time Frame: 15 minutes of water immersion
|
15 minutes of water immersion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Andrew Clark, Castle Hill Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 22, 2016
Primary Completion (ACTUAL)
April 4, 2017
Study Completion (ACTUAL)
April 4, 2017
Study Registration Dates
First Submitted
October 13, 2016
First Submitted That Met QC Criteria
October 28, 2016
First Posted (ESTIMATE)
October 31, 2016
Study Record Updates
Last Update Posted (ACTUAL)
June 19, 2019
Last Update Submitted That Met QC Criteria
June 17, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R1996
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
Clinical Trials on water immersion
-
Universidade Federal do Rio Grande do NorteUnknown
-
McGill UniversityRecruitingAminoacidemia | Sport Recovery | Cold-water ImmersionCanada
-
University of Castilla-La ManchaNot yet recruitingMuscle Fatigue (C23.888.592.612.612) | Athletic Injuries (C26.857.500.124) | Recovery of Function (G11.427.698.620) | Cryotherapy (E02.095.301.250) | Thermotherapy (E02.095.301.750) | Soccer (I03.450.642.845.750) | Biomarkers (D23.050.301) | Thermography (E01.370.350.700.750) | Physical Fitness (G11...
-
German Institute of Human NutritionRecruitingQuality of Life | Stress | Behavior | Psychological WellbeingGermany
-
Vitkovice HospitalCompleted
-
Coventry UniversityCompleted
-
Coventry UniversityBritish Society for Research on AgeingCompletedAging | Physical InactivityUnited Kingdom
-
Centre d'Investigation Clinique et Technologique...Fondation GarchesCompleted
-
University of Nevada, Las VegasCompletedStress Disorders, Post-TraumaticUnited States
-
University of Maryland, BaltimoreCompletedRight Sided Cardiac FailureUnited States